Research map: Cost-effectiveness of BPaL-based and 9-month modified all-oral short treatment regimens for rifampicin-resistant tuberculosis in Belarus

Back to the article

Papers in this map

  1. Decision Modelling For Health Economic Evaluation · Andrew H. Briggs · 2006 · 3155 citations · Cited by this paper
  2. Traditional bone setter practices and the interaction with biomedical care in the treatment of hip fractures in The Gambia: A qualitative study · 2026 · Related
  3. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations · Don Husereau · 2022 · 1125 citations · Cited by this paper
  4. Leveraging current capacity to address the high prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in South Africa: Modelling potential costs and benefits of near point-of-care GeneXpert testing for STIs · 2026 · Related
  5. Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research · Beth S. Woods · 2016 · 951 citations · Cited by this paper
  6. Physical activity levels and associated factors among Rohingya older adults living in the refugee camp in Bangladesh · 2026 · Related
  7. The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought · Thomas Wilkinson · 2016 · 354 citations · Cited by this paper
  8. Estimating the human development impacts and economic returns from an adolescent cash ‘plus’ programme in Kenya: An economic modelling study · 2026 · Related
  9. Global wage report 2024-25 · 2024 · 175 citations · Cited by this paper
  10. Prevalence of lead poisoning and unique lead sources in Bhutan: Findings from a nationally representative survey 2024 · 2026 · Related
  11. Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial · Bern-Thomas Nyang’wa · 2023 · 108 citations · Cited by this paper
  12. Barriers and facilitators to tele-support psychotherapy versus standard in-person mental health services for youth (15–30 Years) with depression in Kampala District, Uganda · 2026 · Related
  13. Post-tuberculosis mortality and morbidity: valuing the hidden epidemic · Matthew Quaife · 2020 · 90 citations · Cited by this paper
  14. Parents’ and guardians’ perceptions of sexual and reproductive health communication with youth: A qualitative study in Gurage Zone, Southern Ethiopia · 2026 · Related
  15. Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis · Christiaan Mulder · 2022 · 37 citations · Cited by this paper
  16. Non-communicable disease care in peri-urban Nepal: Potential for community-based interventions · 2026 · Related
  17. Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis · Sedona Sweeney · 2022 · 37 citations · Cited by this paper
  18. Popular health surveillance in the face of climate emergencies · 2026 · Related
  19. Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines · Gabriela B. Gomez · 2021 · 36 citations · Cited by this paper
  20. Modelling climatic and temporal dynamics of dengue transmission in Bangladesh using deep learning models · 2026 · Related
  21. Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study · Oleksandr Korotych · 2024 · 27 citations · Cited by this paper
  22. Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysis · Denise Hawkins Evans · 2024 · 16 citations · Cited by this paper
  23. The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan · Animesh Sinha · 2025 · 16 citations · Cited by this paper
  24. 24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluation · Sedona Sweeney · 2025 · 8 citations · Cited by this paper
  25. A systematic review of economic evaluations of pharmacological treatments for active tuberculosis · Sarosh Nagar · 2024 · 3 citations · Cited by this paper
  26. Cost-effectiveness of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis in Belarus, Georgia, Kazakhstan and the Republic of Moldova · Kasim Allel · 2025 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)